Brightsurf Science News & Current Events

December 12, 2009
M. D. Anderson study questions true favorability of rare breast cancer type
In a large review of breast cancer patients with mucinous carcinoma, researchers at the University of Texas M.

Antibody-guided drug shows encouraging activity in metastatic breast cancer
A new antibody-drug compound shrank or halted the growth of metastatic breast tumors in almost half of a group of patients whose HER2-positive cancer had become resistant to standard therapies, according to early data from a multicenter Phase 2 clinical trial led by a Dana-Farber Cancer Institute researcher.

Mayo Clinic researchers say breast cancer survival improves Herceptin used with chemotherapy
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to